Our Resources

Studying a medical device for the treatment of overactive bladder. ObvioHealth is conducting an innovative study seeking FDA approval of a wearable neuromodulation device for the treatment of overactive bladder (OAB).

A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.

Capturing and assessing patient-reported outcomes is key to driving patient centricity in healthcare research and delivery. However, the life sciences industry has frequently struggled to gather adequate, high-quality participant data in clinical trials, resulting in costly delays for study teams.

A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products post CE-mark, in accordance with MDR 2017/745 Annex XIV Part B.

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.